These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19452288)

  • 1. New targets of PS-341: BAFF and APRIL.
    Li W; Li J; Su C; Zou WY; Luo S
    Med Oncol; 2010 Jun; 27(2):439-45. PubMed ID: 19452288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of BAFF/APRIL mRNA expression induced by glucocorticoid and bortezomib in multiple myeloma cells in vitro].
    Li LS; Shen JK; Zhang GS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1419-23. PubMed ID: 22169295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.
    Moreaux J; Legouffe E; Jourdan E; Quittet P; Rème T; Lugagne C; Moine P; Rossi JF; Klein B; Tarte K
    Blood; 2004 Apr; 103(8):3148-57. PubMed ID: 15070697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.
    He B; Chadburn A; Jou E; Schattner EJ; Knowles DM; Cerutti A
    J Immunol; 2004 Mar; 172(5):3268-79. PubMed ID: 14978135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular membrane-based vesicles displaying a reconstructed B cell maturation antigen for multiple myeloma therapy by dual targeting APRIL and BAFF.
    He C; Zhang M; Liu L; Han Y; Xu Z; Xiong Y; Yan F; Su D; Chen H; Zheng Y; Cheng F
    Acta Biomater; 2022 Apr; 143():406-417. PubMed ID: 35218967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha.
    Nishio M; Endo T; Tsukada N; Ohata J; Kitada S; Reed JC; Zvaifler NJ; Kipps TJ
    Blood; 2005 Aug; 106(3):1012-20. PubMed ID: 15860672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role of both NF-κB pathways in expression and transcription regulation of BAFF-R gene in multiple myeloma cells.
    Shen X; Zhu W; Zhang X; Xu G; Ju S
    Mol Cell Biochem; 2011 Nov; 357(1-2):21-30. PubMed ID: 21607696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APRIL is overexpressed in cancer: link with tumor progression.
    Moreaux J; Veyrune JL; De Vos J; Klein B
    BMC Cancer; 2009 Mar; 9():83. PubMed ID: 19291294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway.
    Kern C; Cornuel JF; Billard C; Tang R; Rouillard D; Stenou V; Defrance T; Ajchenbaum-Cymbalista F; Simonin PY; Feldblum S; Kolb JP
    Blood; 2004 Jan; 103(2):679-88. PubMed ID: 14504101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.
    Hideshima T; Richardson P; Chauhan D; Palombella VJ; Elliott PJ; Adams J; Anderson KC
    Cancer Res; 2001 Apr; 61(7):3071-6. PubMed ID: 11306489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies.
    Shivakumar L; Ansell S
    Clin Lymphoma Myeloma; 2006 Sep; 7(2):106-8. PubMed ID: 17026820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAFF is involved in macrophage-induced bortezomib resistance in myeloma.
    Chen J; He D; Chen Q; Guo X; Yang L; Lin X; Li Y; Wu W; Yang Y; He J; Zhang E; Yi Q; Cai Z
    Cell Death Dis; 2017 Nov; 8(11):e3161. PubMed ID: 29095438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts.
    Yaccoby S; Pennisi A; Li X; Dillon SR; Zhan F; Barlogie B; Shaughnessy JD
    Leukemia; 2008 Feb; 22(2):406-13. PubMed ID: 18046446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.
    Chiu A; Xu W; He B; Dillon SR; Gross JA; Sievers E; Qiao X; Santini P; Hyjek E; Lee JW; Cesarman E; Chadburn A; Knowles DM; Cerutti A
    Blood; 2007 Jan; 109(2):729-39. PubMed ID: 16960154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells.
    Chauhan D; Li G; Podar K; Hideshima T; Neri P; He D; Mitsiades N; Richardson P; Chang Y; Schindler J; Carver B; Anderson KC
    Cancer Res; 2005 Sep; 65(18):8350-8. PubMed ID: 16166312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the Mechanism of Selective Interaction of BR3 and BCMA with BAFF and APRIL.
    Li L; Jiang Y; Su L; Feng D; Wei J; Sun J
    Protein Pept Lett; 2020; 27(11):1114-1123. PubMed ID: 32282294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappa B as a therapeutic target in multiple myeloma.
    Hideshima T; Chauhan D; Richardson P; Mitsiades C; Mitsiades N; Hayashi T; Munshi N; Dang L; Castro A; Palombella V; Adams J; Anderson KC
    J Biol Chem; 2002 May; 277(19):16639-47. PubMed ID: 11872748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAFF inhibition: a new class of drugs for the treatment of autoimmunity.
    Liu Z; Davidson A
    Exp Cell Res; 2011 May; 317(9):1270-7. PubMed ID: 21333645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.
    Kayagaki N; Yan M; Seshasayee D; Wang H; Lee W; French DM; Grewal IS; Cochran AG; Gordon NC; Yin J; Starovasnik MA; Dixit VM
    Immunity; 2002 Oct; 17(4):515-24. PubMed ID: 12387744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.